Inhibiting MDM2 oncogene expression as a novel approach to human cancer therapy.

被引：0
|
作者：
Wang, H
Agrawal, S
Zhang, R
机构：
[1] Hybridon Inc, Milford, MA USA
[2] Univ Alabama, Div Clin Pharmacol, Birmingham, AL 35294 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2000年 / 67卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OIIA4
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [1] MDM2 oncogene as a novel target for human cancer therapy
    Zhang, RW
    Wang, H
    CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (04) : 393 - 416
  • [2] MDM2 oncogene as a target for cancer therapy: An antisense approach
    Wang, H
    Zeng, XF
    Oliver, P
    Le, LP
    Chen, JD
    Chen, LH
    Zhou, WQ
    Agrawal, S
    Zhang, RW
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (04) : 653 - 660
  • [3] An overview of PROTACs targeting MDM2 as a novel approach for cancer therapy
    Li, Huiwen
    Cai, Xinhui
    Yang, Xiaoyu
    Zhang, Xuan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 272
  • [4] PROTAC design of Mdm2 degraders: A novel efficient approach for cancer therapy
    Li, Yangbing
    Yang, Jiuling
    Aguilar, Angelo
    Lu, Jianfeng
    McEachern, Donna
    Bernard, Denzil
    Wang, Shaomeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [5] Detection of mdm2 oncogene expression in laryngeal leukoplakia
    Suzuki, T
    Iwatake, H
    Tsutsumi, K
    Kato, I
    Takakuwa, T
    SYDNEY '97 - XVI WORLD CONGRESS OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY, TOMES 1 AND 2, 1996, : 1339 - 1342
  • [6] Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: In vitro and in vivo activities and mechanisms
    Wang, H
    Yu, D
    Agrawal, S
    Zhang, RW
    PROSTATE, 2003, 54 (03): : 194 - 205
  • [7] Targeted MDM2 degradation as a novel and efficacious cancer therapy
    Yang, Jiuling
    Li, Yangbing
    Aguilar, Angelo
    McEachern, Donna
    Przybranowski, Sally
    Fernandez-Salas, Ester
    Lu, Jianfeng
    CANCER RESEARCH, 2018, 78 (13)
  • [8] MDM2 inhibitors for cancer therapy
    Vassilev, Lyubomir T.
    TRENDS IN MOLECULAR MEDICINE, 2007, 13 (01) : 23 - 31
  • [9] The regulation of MDM2 oncogene and its impact on human cancers
    Zhao, Yuhan
    Yu, Haiyang
    Hu, Wenwei
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2014, 46 (03) : 180 - 189
  • [10] The mdm2 proto-oncogene
    Haines, DS
    LEUKEMIA & LYMPHOMA, 1997, 26 (3-4) : 227 - 238
12345